Abstract
Mitral annular calcification (MAC) is a chronic process that presents a complex clinical pathology. In the setting of a growing elderly population, the incidence of MAC has been increasing and it is often associated with other degenerative conditions most importantly atherosclerosis. While its clinical impact has previously been underappreciated, more recent evidence suggests that MAC has significant implications on cardiovascular and cerebrovascular morbidity as well as mortality. Commonly MAC is associated with mitral valve disease, which can require non-medical treatment in the form of conventional mitral valve surgery, transcatheter mitral valve replacement or a hybrid approach. The presence of MAC has important implications on both the interventional methods and subsequently on clinical outcomes. This review focuses on the diagnosis, clinical implications, and implications on mitral valve surgery and/or transcatheter interventions of MAC.